Overview
AFJK market data
Price History
AFJK price chart
Valuation & Profitability
- P/E (TTM)
- 41.14 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.33 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.62 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.75 – $130.37 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $37.9M · P/B 48.73.
Company News
Aimei Health Technology Q2 EPS $(0.03) Down From $0.07 YoYBenzinga · Aug 13, 2026, 12:21 PM
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 ResultsBenzinga · Jul 9, 2026, 4:05 PM
Nasdaq Gains 100 Points; US Initial Jobless Claims Edge LowerBenzinga · Jul 9, 2026, 1:50 PM
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.Globenewswire Inc · Jul 8, 2026, 9:15 PM
Aimei Health Technology Terminates The Business Combination Agreement With United Hydrogen GroupBenzinga · Jul 8, 2026, 9:10 PM
Aimei Health Technology Received Nasdaq Listing Notice On May 19 After Missing Deadline to File Form 10-Q By May 15; Company has 60 Days To Regain Listing StatusBenzinga · May 20, 2026, 8:20 PM